Gossamer Bio, Inc. (GOSS) Return on equity 2022–2024
Gossamer Bio, Inc. (GOSS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-191.7%FY2024 · since FY2022: -1899.3% → -191.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -191.7% | +94.8 pp |
| FY2023 | -286.5% | +1612.8 pp |
| FY2022 | -1899.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice